Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/06/2003WO2003018785A1 Mutant helper phasge for isolation of antibody molecules in phage display
03/06/2003WO2003018777A1 A universal light-switchable gene promoter system
03/06/2003WO2003018775A2 Human mitochondrial dna polymorphisms, haplogroups, associations with physiological conditions, and genotyping arrays
03/06/2003WO2003018771A2 A system for antibody expression and assembly
03/06/2003WO2003018770A2 Amplified oncogenes and their involvement in cancer
03/06/2003WO2003018768A2 Transmembrane protein differentially expressed in cancer
03/06/2003WO2003018766A2 Self-processing plants and plant parts
03/06/2003WO2003018765A2 A high throughput method for identification of sequence tags
03/06/2003WO2003018764A2 Novel human proteases and polynucleotides encoding the same
03/06/2003WO2003018760A2 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
03/06/2003WO2003018759A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
03/06/2003WO2003018758A2 Reagents and methods for smooth muscle therapies
03/06/2003WO2003018756A2 Methods for preparing purified prostaglandin e synthase
03/06/2003WO2003018755A2 Wild-type ras as a cancer therapeutic agent
03/06/2003WO2003018754A2 Neural regeneration peptide and methods for their use in treatment of brain damage
03/06/2003WO2003018751A2 Apparatus and method for electroporation of biological samples
03/06/2003WO2003018750A2 Molecular interaction sites of 23s ribosomal rna and methods of use
03/06/2003WO2003018746A2 Estrogen receptor alpha variants and methods of detection thereof
03/06/2003WO2003018745A2 Method of screening for drug hypersensitivity reaction
03/06/2003WO2003018744A2 Transgenic mammal capable of facilitating production of donor-specific functional immunity
03/06/2003WO2003018742A2 Recombinant l-asparaginase erwinia caratovora
03/06/2003WO2003018636A2 Chimaeric peptides of insulin, their compositions and use in treating diabetes
03/06/2003WO2003018635A1 Human cdr-grafted antibodies and antibody fragments thereof
03/06/2003WO2003018632A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto
03/06/2003WO2003018631A2 Nogo receptor homologues and their use
03/06/2003WO2003018630A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003WO2003018628A1 Gene controlling flowering time and method for controlling flowering time in plants using the gene
03/06/2003WO2003018627A1 Gene controlling life span of leaves in plants and method for controlling life span of plants using the gene
03/06/2003WO2003018626A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
03/06/2003WO2003018625A2 Allelic variants of herv-k18 provirus and their use in analysis
03/06/2003WO2003018624A1 Vectors, constructs, and transgenic plants for hpv-11 and hpv-16 l1 capsid protein
03/06/2003WO2003018623A2 Papillomavirus proteins and pharmaceutical compositions
03/06/2003WO2003018622A1 Pseudovirions comprising virus capsids, histones and nucleic acids as therapeutic agents
03/06/2003WO2003018620A2 Serine protease inhibitor and processes for the preparation thereof
03/06/2003WO2003018616A1 A method of sequestering and/or purifying a polypeptide
03/06/2003WO2003018612A2 Extracellular messengers
03/06/2003WO2003018611A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003WO2003018601A1 Use of antisense oligonucleotide libraries for identifying gene function
03/06/2003WO2003018600A2 Antisense modulation of microsomal triglyceride transfer protein expression
03/06/2003WO2003018595A2 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
03/06/2003WO2003018134A2 Bioadhesive compositions and methods for enhanced mucosal drug absorption
03/06/2003WO2003018065A1 Anti-cancer agents comprising disintegrin genes and the treating methods
03/06/2003WO2003018055A1 Vaccine using papilloma virus e proteins delivered by viral vector
03/06/2003WO2003018052A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003WO2003018044A1 New drug
03/06/2003WO2003017944A2 Gpi-anchored cytokines
03/06/2003WO2003017935A2 Human antibodies specific for interleukin 15 (il-15)
03/06/2003WO2003017918A2 A method of inducing the formation of neurofibrillary tangles in transgenic animals
03/06/2003WO2003017917A2 Use of microbiology non-viral substances for treating acne
03/06/2003WO2003017825A2 Methods of treating obesity
03/06/2003WO2003017817A2 Diagnosis, prevention and treatment of cancer
03/06/2003WO2003017780A1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
03/06/2003WO2003017756A1 Rat highly sensitive to carcinogen
03/06/2003WO2003017755A2 Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
03/06/2003WO2003017753A2 Reverse breeding
03/06/2003WO2003017752A1 In planta transformation by embryo imbibition of agrobacterium
03/06/2003WO2003017751A2 Combinations of genes for producing seed plants exhibiting modulated reproductive development
03/06/2003WO2003004626A9 A bioprocess for the generation of cells derived from spheroid-forming cells
03/06/2003WO2003000729A3 Secreted polypeptide and their use in the treatment of bone disorders
03/06/2003WO2002101021A3 Purification of human serum albumin
03/06/2003WO2002099097A8 Novel compounds for chemiluminescense procedures
03/06/2003WO2002096469A3 Gene delivery via a baculovirus vector
03/06/2003WO2002095036A8 A novel intein and uses thereof
03/06/2003WO2002094848A8 Treatment of mycobacterium tuberculosis with antisense oligonucleotides
03/06/2003WO2002092122A3 Use of osteopontin for the treatment and/or prevention of neurologic diseases
03/06/2003WO2002088319A3 Mini-adenoviral vector and methods of using same
03/06/2003WO2002088178A8 Antigens of group b streptococcus and corresponding dna fragments
03/06/2003WO2002086097A3 Methods for identifying the target of a compound which inhibits cellular proliferation
03/06/2003WO2002086069A3 Secreted proteins
03/06/2003WO2002085945A3 Vhh single heavy chain antibody and a method for its preparation in a mammal
03/06/2003WO2002081709A3 Modified hpv e6 and e7 genes and proteins useful for vaccination
03/06/2003WO2002081683A3 Protein analysis by means of immobilized arrays of antigens or antibodies
03/06/2003WO2002080755A9 Kits and methods for assessing oxidative stress
03/06/2003WO2002079446A3 Transgenic mice containing gpr31 gene disruptions
03/06/2003WO2002079438A3 Ogri gene disruptions, compositions and methods relating thereto
03/06/2003WO2002079399A8 Regulatable growth of filamentous fungi
03/06/2003WO2002078437A3 Novel pesticidal toxins
03/06/2003WO2002078427A3 Specification of meiocyte and tapetal cell layers in plants
03/06/2003WO2002077276A3 Novel signalling polypeptide
03/06/2003WO2002074928A3 Fusion peptides isolatable by phase transition
03/06/2003WO2002074249A3 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
03/06/2003WO2002074243A9 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
03/06/2003WO2002070651A3 Viral reporter particles
03/06/2003WO2002064731A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/06/2003WO2002064092A3 Method for evaluating therapeutic efficacy
03/06/2003WO2002062959A3 Hepatitis b virus treatment
03/06/2003WO2002060929A3 Polymer conjugates of neublastin and methods of using same
03/06/2003WO2002059302A3 Regulation of human serotonin-like g protein-coupled receptor
03/06/2003WO2002059264A3 Specific human antibodies for selective cancer therapy
03/06/2003WO2002059262A3 Compositions and methods for detecting proteolytic activity
03/06/2003WO2002057293A3 Modified zinc finger binding proteins
03/06/2003WO2002056837A3 Inhibition of protein-phosphatases for the treatment of heart failure
03/06/2003WO2002055719A3 Expression of foreign genes from plant virus vectors
03/06/2003WO2002053753A3 Novel human lipase and polynucleotides encoding the same
03/06/2003WO2002053579A3 Haplotypes of the fmo2 gene
03/06/2003WO2002052013A3 The flu gene: a tool for the identification of genes involved in stress responses and apoptosis and a target for herbicides specific for angiosperms
03/06/2003WO2002051994A8 Polypeptides
03/06/2003WO2002050273A3 A transmembrane protein as a downstream target of neurotrophin and ephrin receptor tyrosine kinases, dna encoding same monoclonal antibodies thereto
03/06/2003WO2002050264A3 Promoters and recombinant expression constructs
03/06/2003WO2002046436A3 Plasmid vectors
1 ... 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 ... 4023